ClinConnect ClinConnect Logo
Search / Trial NCT06401239

Investigating Dyadic Expectations About ARF Survivorship (IDEAS)

Launched by JOHNS HOPKINS UNIVERSITY · May 2, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Arf Survivor Caregiver Icu Recovery Dyadic Coping Dyadic Self Efficacy

ClinConnect Summary

The IDEAS trial is studying the recovery process for adults who survive acute respiratory failure (ARF) and the family members or friends who support them during the first six months at home. The goal is to understand how both survivors and their caregivers feel about recovery and if their expectations about the healing process are linked to mental health issues. Participants will complete three surveys over six months, which will ask about their feelings, moods, and outlook on the future. These surveys can be filled out online, over the phone, or on paper, making it easy for everyone involved.

To join the study, survivors must be at least 18 years old, have survived a hospital stay for ARF, and have a caregiver who can support them for at least six months. They should be able to read or speak English or Spanish. However, those with serious cognitive issues or who live in a hospital setting at discharge are not eligible. Caregivers must also be at least 18 years old and can communicate in English or Spanish. This trial is important because it aims to improve understanding of recovery from ARF, helping both survivors and their caregivers manage the emotional and mental challenges they may face.

Gender

ALL

Eligibility criteria

  • Patient Inclusion Criteria:
  • ≥18 years old
  • * Meets study definition of ARF:
  • * The study defines ARF as meeting 1 of the following 3:
  • 1. Mechanical ventilation via an endotracheal tube ≥24 consecutive hours OR
  • 2. Non-invasive ventilation (CPAP, BiPAP) ≥24 consecutive hours that is not for obstructive sleep apnea or other stable use OR
  • 3. High flow nasal cannula with fraction of inspired oxygen (FIO2)≥.5 and flow rate ≥ litres per minute (LPM) for ≥24 consecutive hours.
  • Occasional rest periods of ≤1 hour are not deducted from the calculation of consecutive hours. Patients who are intubated for mental status or airway obstruction are not eligible unless they have simultaneous ARF.
  • Survival to hospital discharge to home
  • Speaks or reads English or Spanish
  • Identifies an adult who is expected to act as a primary care partner for at least the next 6 months.
  • Patient Exclusion Criteria:
  • Pre-existing cognitive impairment (IQ-CODE \>3.6)
  • Residing in a medical institution at hospital discharge
  • Receiving hospice care or life expectancy \<6 months
  • Homelessness or recent history of psychosis
  • Care Partner Inclusion Criteria:
  • ≥18 years old
  • Speaks or reads English or Spanish
  • Care Partner Exclusion Criteria:
  • Pre-existing cognitive impairment (IQ-CODE \>3.6)

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Alison E Turnbull, PhD

Principal Investigator

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported